Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02676882 · ClinicalTrials.gov registry record · NA
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
A NA study of Pregnancy and Depressive Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02676882 is a NA study of Pregnancy and Depressive Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02676882, a NA study of Pregnancy and Depressive Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness of the EnBrace HR prenatal supplement in preventing depression in women with a history of depression who have decided to stop taking antidepressants during their pregnancy, or treating women who are currently in a depressive episode while pregnant or planning pregnancy.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT EnBrace HR
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-01-24 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02676882
The ClinicalTrials.gov registry entry for NCT02676882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which EnBrace HR is the first listed.
NCT02676882 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02676882 about?
NCT02676882 is a clinical study titled "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy". The purpose of this study is to assess the effectiveness of the EnBrace HR prenatal supplement in preventing depression in women with a history of depression who have decided to stop taking antidepressants during their pregnancy, or treating women who are currently in a depressive episode while preg...
What is the current status of trial NCT02676882?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-01-24. Estimated completion is 2018-11-30.
What conditions does trial NCT02676882 study?
This clinical trial studies the following conditions: Pregnancy, Depressive Disorder.
What interventions are being tested in trial NCT02676882?
The interventions under investigation include: EnBrace HR (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02676882?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02676882 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.